Claude Nicaise is a director of Gain Therapeutics Inc.
Person profile
Roles
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
CASSAVA SCIENCES INC
13 May 24
4
Sarepta Therapeutics, Inc.
5 Mar 24
4
CASSAVA SCIENCES INC
8 Dec 23
3
CASSAVA SCIENCES INC
8 Dec 23
4
Gain Therapeutics, Inc.
26 Jun 23
4
Chemomab Therapeutics Ltd.
23 Mar 23
4
Sarepta Therapeutics, Inc.
8 Mar 23
4
Gain Therapeutics, Inc.
22 Sep 22
4
Chemomab Therapeutics Ltd.
9 Mar 22
4
Sarepta Therapeutics, Inc.
8 Mar 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 May 24 | SAVA Cassava Sciences | Stock Option Common Stock | Grant | Acquire A | No | No | 21.11 | 10,000 | 211.10 k | 10,000 |
1 Mar 24 | SRPT Sarepta Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 1,846 | 0.00 | 18,174 |
1 Mar 24 | SRPT Sarepta Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 128.67 | 3,679 | 473.38 k | 3,679 |
6 Dec 23 | SAVA Cassava Sciences | Stock Option Common Stock | Grant | Acquire A | No | No | 21.71 | 20,000 | 434.20 k | 20,000 |
23 Jun 23 | GANX Gain Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.5 | 10,500 | 47.25 k | 10,500 |